< -5%

-5% to -3%

-3% to 0%

Cummins

Swaraj Engines

0% to 3%

3% to 5%

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and appointments, here’s a quick look at which stocks will be in focus in today's trade:

<a href="https://www.moneycontrol.com/markets/earnings/" target="_blank">Results Today</a>

Bajaj Finserv, Tata Power Company, Biocon, Bosch, Awfis Space Solutions, Balrampur Chini Mills, Bharat Forge, Bikaji Foods International, Container Corporation of India, Edelweiss Financial Services, Emcure Pharmaceuticals, ESAF Small Finance Bank, Finolex Cables, Godrej Industries, Hindustan Copper, Apeejay Surrendra Park Hotels, Rail Vikas Nigam, Thermax, Torrent Power, Trualt Bioenergy, TVS Electronics, and Zaggle Prepaid Ocean Services will release their quarterly earnings today.

<a href="https://www.moneycontrol.com/markets/earnings/" target="_blank">Quarterly Earnings</a>

<a href="https://www.moneycontrol.com/india/stockpricequote/finance-nbfc/bajajfinance/BAF" target="_blank">Bajaj Finance</a> Q2 (Consolidated YoY)

Profit increases 23% to Rs 4,948 crore Vs Rs 4,014 crore

Net interest income grows 22% to Rs 10,785 crore Vs Rs 8,838 crore

Assets under management jumps 24% to Rs 4.62 lakh crore Vs Rs 3.73 lakh crore

Gross NPA rises to 1.24% Vs 1.06%

Net NPA climbs to 0.60% Vs 0.46%

<a href="https://www.moneycontrol.com/india/stockpricequote/telecommunication-service-provider/vodafoneidea/IC8" target="_blank">Vodafone Idea</a> Q2 (Consolidated YoY)

Loss narrows to Rs 5,524.2 crore Vs loss of Rs 7,175.9 crore

Revenue grows 2.4% to Rs 11,194.7 crore Vs Rs 10,932.2 crore

EBITDA increases 3% to Rs 4,685.1 crore Vs Rs 4,549.8 crore

Margin expands to 41.9% Vs 41.6%

<a href="https://www.moneycontrol.com/india/stockpricequote/trading/baazarstyleretail/BSR03" target="_blank">Baazar Style Retail</a> Q2 (Consolidated YoY)

Profit stands at Rs 51.5 crore Vs loss of Rs 8.9 crore

Revenue surges 71% to Rs 531.7 crore Vs Rs 310.9 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/personal-care/bajajconsumercare/BC02" target="_blank">Bajaj Consumer Care</a> Q2 (Consolidated YoY)

Profit zooms 32.8% to Rs 42.3 crore Vs Rs 31.8 crore

Revenue grows 13.4% to Rs 265.3 crore Vs Rs 234 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/oil-drillingexploration/gujaratgas/GGC" target="_blank">Gujarat Gas</a> Q2 (Consolidated YoY)

Profit drops 9.4% to Rs 279.8 crore Vs Rs 308.7 crore

Revenue falls 0.03% to Rs 3,780.4 crore Vs Rs 3,781.8 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/electric-equipment/triveniturbine/TT14" target="_blank">Triveni Turbine</a> Q2 (Consolidated YoY)

Profit rises 0.3% to Rs 91.2 crore Vs Rs 90.9 crore

Revenue increases 1% to Rs 506.2 crore Vs Rs 501.1 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/steel-mediumsmall/jindalstainless/JSL01" target="_blank">Jindal Stainless</a> Q2 (Consolidated YoY)

Profit jumps 32% to Rs 806.9 crore Vs Rs 611.3 crore

Revenue soars 11.4% to Rs 10,892.8 crore Vs Rs 9,776.8 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/infrastructure-general/powermechprojects/PMP" target="_blank">Power Mech Projects</a> Q2 (Consolidated YoY)

Profit grows 11.7% to Rs 74.9 crore Vs Rs 67.1 crore

Revenue increases 19.5% to Rs 1,237.9 crore Vs Rs 1,035.5 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/auto-ancillaries-brakes/atherenergy/AEL09" target="_blank">Ather Energy</a> Q2 (YoY)

Loss narrows to Rs 154.1 crore Vs loss of Rs 197.2 crore

Revenue spikes 54% to Rs 898.9 crore Vs Rs 583.5 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/engineering-construction/vikranengineering/VEL01" target="_blank">Vikran Engineering</a> Q2 (YoY)

Profit zooms 339.4% to Rs 9.14 crore Vs Rs 2.08 crore

Revenue grows 10.7% to Rs 176.3 crore Vs Rs 159.2 crore

Vikran receives Letter of Award for 505MWAC solar project in Maharashtra of Rs 1,641.91 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/breweriesdistilleries/sulavineyards/SV01" target="_blank">Sula Vineyards</a> Q2 (Consolidated YoY)

Profit sinks 58.4% to Rs 6.02 crore Vs Rs 14.5 crore

Revenue falls 1.1% to Rs 139.7 crore Vs Rs 141.2 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/engineering-industrial-equipments/syrmasgstechnology/SST06" target="_blank">Syrma SGS Technology</a> Q2 (Consolidated YoY)

Profit zooms 76.8% to Rs 64 crore Vs Rs 36.2 crore

Revenue jumps 37.6% to Rs 1,145.9 crore Vs Rs 832.7 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/printingstationery/domsindustries/DIL04" target="_blank">Doms Industries</a> Q2 (Consolidated YoY)

Profit grows 13.5% to Rs 58.3 crore Vs Rs 51.3 crore

Revenue increases 24% to Rs 567.9 crore Vs Rs 457.8 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/electrodesgraphite/heg/HEG" target="_blank">HEG</a> Q2 (Consolidated YoY)

Profit jumps 74.2% to Rs 143.3 crore Vs Rs 82.3 crore

Revenue soars 23.2% to Rs 699.2 crore Vs Rs 567.6 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/constructioncontracting-real-estate/housingurbandevelopmentcorporation/HUD" target="_blank">Housing &amp; Urban Development Corporation</a> Q2 (Consolidated YoY)

Profit rises 3.1% to Rs 709.8 crore Vs Rs 688.6 crore

Net interest income surges 31.7% to Rs 1,050.4 crore Vs Rs 797.3 crore

Stocks to Watch

Tata Motors

Tata Motors (formerly known as TML Commercial Vehicles) is set to list on the BSE and NSE on November 12 following the implementation of the Composite Scheme of Arrangement.

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/alkemlaboratories/AL05" target="_blank">Alkem Laboratories</a>

The German Health Authority conducted an EU GMP inspection at the company’s manufacturing facility in Baddi during November 4–10, which concluded with no critical or major observations.

<a href="https://www.moneycontrol.com/india/stockpricequote/food-processing/britanniaindustries/BI" target="_blank">Britannia Industries</a>

Varun Berry has resigned as Managing Director &amp; Chief Executive Officer of the company, effective November 10.

The Board has appointed Rakshit Hargave as the new Managing Director and Chief Executive Officer, effective December 15. In the interim, N. Venkataraman, currently the Executive Director and Chief Financial Officer, will hold additional charge as Chief Executive Officer until Rakshit Hargave assumes office.

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/drreddyslaboratories/DRL" target="_blank">Dr Reddy’s Laboratories</a>

Jayanth Sridhar has resigned as Global Head of Biologics, effective January 31, 2026, to pursue aspirations outside the company.

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/glenmarkpharma/GP08" target="_blank">Glenmark Pharmaceuticals</a>

The National Medical Products Administration (NMPA) of China has approved the company’s RYALTRIS Compound Nasal Spray (GSP 301 NS), which is used for the treatment of Allergic Rhinitis (AR) in adults and children.

Block Deals

<a href="https://www.moneycontrol.com/india/stockpricequote/electronics-components/kaynestechnologyindia/KTI" target="_blank">Kaynes Technology India</a>

Goldman Sachs Bank Europe SE-ODI sold 67,702 equity shares (equivalent to 0.1% of paid-up equity) in Kaynes at Rs 6,498 per share, valuing the transaction at Rs 44 crore.

However, Bluepearl Map I LP acquired 65,241 equity shares at the same price for Rs 42.4 crore, while Kadensa Master Fund bought 2,461 equity shares at the same price for Rs 1.6 crore.

Bulk Deals

<a href="https://www.moneycontrol.com/india/stockpricequote/software/aaatechnologies/ATL" target="_blank">AAA Technologies</a>

Nautilus Private Capital acquired an additional 3.7 lakh shares (representing a 2.88% stake) in AAA Technologies at Rs 89.7 per share, amounting to Rs 3.3 crore, from promoter Anjay Ratanlal Agarwal.

Promoter Anjay Ratanlal Agarwal has offloaded a 7.79% stake in the current quarter, while Anjay and other promoters, in total, have sold 19.92% stake in AAA Technologies since the start of October, compared with their total shareholding of 63.93 percent as of September 2025.

Stocks Trade Ex-Dividend

Astral
Chalet Hotels
Chambal Fertilisers &amp; Chemicals
Garden Reach Shipbuilders &amp; Engineers
Indian Metals &amp; Ferro Alloys
Metropolis Healthcare
Nuvama Wealth Management
Saregama India
Siyaram Silk Mills
Steelcast

Stock in F&amp;O ban

SAIL

Ownership, Material Conflicts of Interest and Disciplinary History

MCD is a wholly owned subsidiary of Network 18 Media & Investments Ltd ("Network18"), in which Independent Media Trust (IMT) holds 56.89% stake. Reliance Industries Limited ("RIL") is the sole beneficiary of IMT. Network18 and RIL and their subsidiaries, joint ventures and associates can be considered as associates of MCD.

Details of Associate

Receipt of Compensation

Third-Party Compensation

Employment History

Market-Making Activities

Use of Artificial Intelligence

Stocks to Watch Today: Glenmark Pharma, Alkem Labs, Syrma SGS, Vikran Engineering, Ather Energy, Jindal Stainless, Vodafone, Baazar Style in focus on 11 November

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and appointments, here’s a quick look at which stocks will be in focus in today's trade:

Results Today

Bajaj Finserv, Tata Power Company, Biocon, Bosch, Awfis Space Solutions, Balrampur Chini Mills, Bharat Forge, Bikaji Foods International, Container Corporation of India, Edelweiss Financial Services, Emcure Pharmaceuticals, ESAF Small Finance Bank, Finolex Cables, Godrej Industries, Hindustan Copper, Apeejay Surrendra Park Hotels, Rail Vikas Nigam, Thermax, Torrent Power, Trualt Bioenergy, TVS Electronics, and Zaggle Prepaid Ocean Services will release their quarterly earnings today.

Quarterly Earnings

Bajaj Finance Q2 (Consolidated YoY)

Profit increases 23% to Rs 4,948 crore Vs Rs 4,014 crore

Net interest income grows 22% to Rs 10,785 crore Vs Rs 8,838 crore

Assets under management jumps 24% to Rs 4.62 lakh crore Vs Rs 3.73 lakh crore

Gross NPA rises to 1.24% Vs 1.06%

Net NPA climbs to 0.60% Vs 0.46%

Vodafone Idea Q2 (Consolidated YoY)

Loss narrows to Rs 5,524.2 crore Vs loss of Rs 7,175.9 crore

Revenue grows 2.4% to Rs 11,194.7 crore Vs Rs 10,932.2 crore

EBITDA increases 3% to Rs 4,685.1 crore Vs Rs 4,549.8 crore

Margin expands to 41.9% Vs 41.6%

Baazar Style Retail Q2 (Consolidated YoY)

Profit stands at Rs 51.5 crore Vs loss of Rs 8.9 crore

Revenue surges 71% to Rs 531.7 crore Vs Rs 310.9 crore

Bajaj Consumer Care Q2 (Consolidated YoY)

Profit zooms 32.8% to Rs 42.3 crore Vs Rs 31.8 crore

Revenue grows 13.4% to Rs 265.3 crore Vs Rs 234 crore

Gujarat Gas Q2 (Consolidated YoY)

Profit drops 9.4% to Rs 279.8 crore Vs Rs 308.7 crore

Revenue falls 0.03% to Rs 3,780.4 crore Vs Rs 3,781.8 crore

Triveni Turbine Q2 (Consolidated YoY)

Profit rises 0.3% to Rs 91.2 crore Vs Rs 90.9 crore

Revenue increases 1% to Rs 506.2 crore Vs Rs 501.1 crore

Jindal Stainless Q2 (Consolidated YoY)

Profit jumps 32% to Rs 806.9 crore Vs Rs 611.3 crore

Revenue soars 11.4% to Rs 10,892.8 crore Vs Rs 9,776.8 crore

Power Mech Projects Q2 (Consolidated YoY)

Profit grows 11.7% to Rs 74.9 crore Vs Rs 67.1 crore

Revenue increases 19.5% to Rs 1,237.9 crore Vs Rs 1,035.5 crore

Ather Energy Q2 (YoY)

Loss narrows to Rs 154.1 crore Vs loss of Rs 197.2 crore

Revenue spikes 54% to Rs 898.9 crore Vs Rs 583.5 crore

Vikran Engineering Q2 (YoY)

Profit zooms 339.4% to Rs 9.14 crore Vs Rs 2.08 crore

Revenue grows 10.7% to Rs 176.3 crore Vs Rs 159.2 crore

Vikran receives Letter of Award for 505MWAC solar project in Maharashtra of Rs 1,641.91 crore

Sula Vineyards Q2 (Consolidated YoY)

Profit sinks 58.4% to Rs 6.02 crore Vs Rs 14.5 crore

Revenue falls 1.1% to Rs 139.7 crore Vs Rs 141.2 crore

Syrma SGS Technology Q2 (Consolidated YoY)

Profit zooms 76.8% to Rs 64 crore Vs Rs 36.2 crore

Revenue jumps 37.6% to Rs 1,145.9 crore Vs Rs 832.7 crore

Doms Industries Q2 (Consolidated YoY)

Profit grows 13.5% to Rs 58.3 crore Vs Rs 51.3 crore

Revenue increases 24% to Rs 567.9 crore Vs Rs 457.8 crore

HEG Q2 (Consolidated YoY)

Profit jumps 74.2% to Rs 143.3 crore Vs Rs 82.3 crore

Revenue soars 23.2% to Rs 699.2 crore Vs Rs 567.6 crore

Housing &amp;amp; Urban Development Corporation Q2 (Consolidated YoY)

Profit rises 3.1% to Rs 709.8 crore Vs Rs 688.6 crore

Net interest income surges 31.7% to Rs 1,050.4 crore Vs Rs 797.3 crore

Stocks to Watch

Tata Motors

Tata Motors (formerly known as TML Commercial Vehicles) is set to list on the BSE and NSE on November 12 following the implementation of the Composite Scheme of Arrangement.

Alkem Laboratories

The German Health Authority conducted an EU GMP inspection at the company’s manufacturing facility in Baddi during November 4–10, which concluded with no critical or major observations.

Britannia Industries

Varun Berry has resigned as Managing Director &amp;amp; Chief Executive Officer of the company, effective November 10.

The Board has appointed Rakshit Hargave as the new Managing Director and Chief Executive Officer, effective December 15. In the interim, N. Venkataraman, currently the Executive Director and Chief Financial Officer, will hold additional charge as Chief Executive Officer until Rakshit Hargave assumes office.

Dr Reddy’s Laboratories

Jayanth Sridhar has resigned as Global Head of Biologics, effective January 31, 2026, to pursue aspirations outside the company.

Glenmark Pharmaceuticals

The National Medical Products Administration (NMPA) of China has approved the company’s RYALTRIS Compound Nasal Spray (GSP 301 NS), which is used for the treatment of Allergic Rhinitis (AR) in adults and children.

Block Deals

Kaynes Technology India

Goldman Sachs Bank Europe SE-ODI sold 67,702 equity shares (equivalent to 0.1% of paid-up equity) in Kaynes at Rs 6,498 per share, valuing the transaction at Rs 44 crore.

However, Bluepearl Map I LP acquired 65,241 equity shares at the same price for Rs 42.4 crore, while Kadensa Master Fund bought 2,461 equity shares at the same price for Rs 1.6 crore.

Bulk Deals

AAA Technologies

Nautilus Private Capital acquired an additional 3.7 lakh shares (representing a 2.88% stake) in AAA Technologies at Rs 89.7 per share, amounting to Rs 3.3 crore, from promoter Anjay Ratanlal Agarwal.

Promoter Anjay Ratanlal Agarwal has offloaded a 7.79% stake in the current quarter, while Anjay and other promoters, in total, have sold 19.92% stake in AAA Technologies since the start of October, compared with their total shareholding of 63.93 percent as of September 2025.

Stocks Trade Ex-Dividend

Astral
Chalet Hotels
Chambal Fertilisers &amp;amp; Chemicals
Garden Reach Shipbuilders &amp;amp; Engineers
Indian Metals &amp;amp; Ferro Alloys
Metropolis Healthcare
Nuvama Wealth Management
Saregama India
Siyaram Silk Mills
Steelcast

Stock in F&amp;amp;O ban

SAIL

Goldman Sachs has offloaded a 0.1 percent equity stake in Kaynes Technology India, the electronics manufacturer, through open market transactions on November 10.

Shares of <a href="https://www.moneycontrol.com/india/stockpricequote/electronics-components/kaynestechnologyindia/KTI">Kaynes Technology</a> rallied 4.13 percent to Rs 6,482 after a sharp fall in the previous couple of sessions.

Goldman Sachs Bank Europe SE-ODI sold 67,702 equity shares (equivalent to 0.1 percent of paid-up equity) in Kaynes at Rs 6,498 per share, valuing the transaction at Rs 44 crore.

However, Bluepearl Map I LP acquired 65,241 equity shares at the same price for Rs 42.4 crore, while Kadensa Master Fund bought 2,461 equity shares at the same price for Rs 1.6 crore.

Meanwhile, <a href="https://www.moneycontrol.com/india/stockpricequote/software/aaatechnologies/ATL">AAA Technologies</a> remained in focus as the promoter continued to be a net seller in the stock, which declined 1.5 percent to Rs 90.63. Nautilus Private Capital acquired an additional 3.7 lakh shares (representing a 2.88 percent stake) in the company at Rs 89.7 per share, amounting to Rs 3.3 crore, from promoter Anjay Ratanlal Agarwal.

Promoter Anjay Ratanlal Agarwal has offloaded a 7.79 percent stake in the current quarter, while Anjay and other promoters, in total, have sold 19.92 percent stake in AAA Technologies since the start of October, compared with their total shareholding of 63.93 percent as of September 2025.

Goldman Sachs sells 0.1% stake in Kaynes Technology for Rs 44 crore

Goldman Sachs has offloaded a 0.1 percent equity stake in Kaynes Technology India, the electronics manufacturer, through open market transactions on November 10.

Shares of Kaynes Technology rallied 4.13 percent to Rs 6,482 after a sharp fall in the previous couple of sessions.

Goldman Sachs Bank Europe SE-ODI sold 67,702 equity shares (equivalent to 0.1 percent of paid-up equity) in Kaynes at Rs 6,498 per share, valuing the transaction at Rs 44 crore.

However, Bluepearl Map I LP acquired 65,241 equity shares at the same price for Rs 42.4 crore, while Kadensa Master Fund bought 2,461 equity shares at the same price for Rs 1.6 crore.

Meanwhile, AAA Technologies remained in focus as the promoter continued to be a net seller in the stock, which declined 1.5 percent to Rs 90.63. Nautilus Private Capital acquired an additional 3.7 lakh shares (representing a 2.88 percent stake) in the company at Rs 89.7 per share, amounting to Rs 3.3 crore, from promoter Anjay Ratanlal Agarwal.

Promoter Anjay Ratanlal Agarwal has offloaded a 7.79 percent stake in the current quarter, while Anjay and other promoters, in total, have sold 19.92 percent stake in AAA Technologies since the start of October, compared with their total shareholding of 63.93 percent as of September 2025.

Shares of Graphite India and Epigral came under pressure on Monday after the companies reported weak earnings for the quarter ended September 30, 2025, while Krsnaa Diagnostics rose on strong results.

<a href="https://www.moneycontrol.com/india/stockpricequote/electrodesgraphite/graphiteindia/GI13">Graphite India</a> settled 7.23 percent lower at Rs 535.50 on the NSE after the company posted a 60.5 percent decline in consolidated net profit to Rs 77 crore for the September quarter, compared with Rs 195 crore in the year-ago period. The fall in profit was attributed to lower electrode prices and weaker operating margins.

<a href="https://www.moneycontrol.com/india/stockpricequote/speciality-chemicals/epigral/MF23">Epigral</a> shares closed 7.65 percent down at Rs 1,522 apiece after the chemical manufacturer reported a 37 percent year-on-year drop in net profit to Rs 51.2 crore from Rs 81.3 crore. Revenue from operations slipped 6.2 percent to Rs 587.3 crore from Rs 626 crore a year earlier.

Krsnaa Diagnostics shares advanced 8 percent to close at Rs 781.50 on the NSE after the company reported a 22 percent rise in net profit to Rs 23.94 crore for the September quarter.

According to data compiled by LSEG, the stock has a “Buy” rating on average from three analysts, with a median price target of Rs 1,127. Around 5.66 lakh shares changed hands on the exchange, sharply higher than the 30-day average volume of 71,926 shares. Year-to-date, the stock is down 7.5 percent.

(Reuters Inputs) 

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Q2 results impact: Graphite India, Epigral shares decline up to 7% on weak earnings, Krsnaa Diagnostics rises 8%

Shares of Graphite India and Epigral came under pressure on Monday after the companies reported weak earnings for the quarter ended September 30, 2025, while Krsnaa Diagnostics rose on strong results.

Graphite India settled 7.23 percent lower at Rs 535.50 on the NSE after the company posted a 60.5 percent decline in consolidated net profit to Rs 77 crore for the September quarter, compared with Rs 195 crore in the year-ago period. The fall in profit was attributed to lower electrode prices and weaker operating margins.

Epigral shares closed 7.65 percent down at Rs 1,522 apiece after the chemical manufacturer reported a 37 percent year-on-year drop in net profit to Rs 51.2 crore from Rs 81.3 crore. Revenue from operations slipped 6.2 percent to Rs 587.3 crore from Rs 626 crore a year earlier.

Krsnaa Diagnostics shares advanced 8 percent to close at Rs 781.50 on the NSE after the company reported a 22 percent rise in net profit to Rs 23.94 crore for the September quarter.

According to data compiled by LSEG, the stock has a “Buy” rating on average from three analysts, with a median price target of Rs 1,127. Around 5.66 lakh shares changed hands on the exchange, sharply higher than the 30-day average volume of 71,926 shares. Year-to-date, the stock is down 7.5 percent.

(Reuters Inputs) 

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

The shares of IT stocks jumped in trade on November 10, pushing the Nifty IT index up nearly 2 percent to emerge as the top sectoral gainer on the market today. The index has now snapped a six-session losing streak.

The Nifty IT index stood at 35,760.60, as seen at 1.30 pm as investors resorted to value-buying after sharp correction during the losing streak. The investor sentiment was further boosted by hopes for a nearing end to the ongoing US government shutdown.

Value-buying:

The <a href="https://www.moneycontrol.com/indian-indices/nifty-it-19.html">Nifty IT index</a> dropped nearly 2.7 percent while recording sharp losses from October 30 to November 7. This came after the index surged more than 7 percent earlier in October as better-than-expected Q2 results and positive outlook for the second half of the ongoing financial year boosted investor sentiment.

This came despite delays to US-India trade deal negotiations

Hopes of nearing end to US government shutdown:

The US Senate on November 9 moved ahead with a measure aimed at reopening the federal government and <a href="https://www.moneycontrol.com/world/senate-nears-deal-to-end-record-us-government-shutdown-article-13662236.html">ending a now 40-day-long shutdown</a>. In a procedural vote, senators advanced a House-passed bill that will be amended to fund the government until January 30 and include a package of three full-year appropriations bills.

If the Senate passed the amended measure, it will be sent for approval by the House of Representatives and then to President Donald Trump for his signature. “It looks like we’re getting very close to the shutdown ending,” Trump told reporters at the White House.

As part of the shutdown, many government services have been suspended and hundreds of thousands of federal employees have been ordered not to work.

"A possible end to the longest running U.S. shutdown is a positive for markets. Our expectation is that the next step is for a House vote on Wednesday, with the government set to re-open this Friday," said Prashant Newnaha, senior Asia-Pacific rates strategist at TD Securities.

Indian IT companies derive a major portion of their revenue from the US market. The potential end to the US shutdown in America may have boosted investor confidence for these stocks.

Jefferies in September chose TCS and Infosys as its top picks about the largecap IT stocks. It noted that both are “well placed” to deal with the $100K visa fell for the Indian IT sector.

Among the midcap stocks, Jefferies prefers Coforge.

Top IT gainers today:

<a href="https://www.moneycontrol.com/india/stockpricequote/computers-software/infosys/IT">Infosys</a> shares were the top gainer on the Nifty IT index, rising nearly 3 percent to trade at Rs 1,519.70 apiece. <a href="https://www.moneycontrol.com/india/stockpricequote/computers-software/hcltechnologies/HCL02">HCL Tech</a>, LTI Mindtree, <a href="https://www.moneycontrol.com/india/stockpricequote/computers-software/wipro/W">Wipro</a> and Mphasis shares meanwhile gained nearly 2 percent each.

Persistent Systems, Tata Consultancy Services (<a href="https://www.moneycontrol.com/india/stockpricequote/computers-software/tataconsultancyservices/TCS">TCS</a>), Coforge and <a href="https://www.moneycontrol.com/india/stockpricequote/computers-software/techmahindra/TM4">Tech Mahindra</a> shares rose over 1 percent each.

Also read: <a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-sensex-nifty-50-share-price-gift-nifty-latest-updates-10-11-2025-liveblog-13662226.html">Our LIVE blog on stock market updates</a>

(With inputs from Reuters)

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

IT index rises nearly 2%, snaps 6-day losses on hopes of end to US govt shutdown; Infosys, HCLTech rise up to 3%

The shares of IT stocks jumped in trade on November 10, pushing the Nifty IT index up nearly 2 percent to emerge as the top sectoral gainer on the market today. The index has now snapped a six-session losing streak.

The Nifty IT index stood at 35,760.60, as seen at 1.30 pm as investors resorted to value-buying after sharp correction during the losing streak. The investor sentiment was further boosted by hopes for a nearing end to the ongoing US government shutdown.

Value-buying:

The Nifty IT index dropped nearly 2.7 percent while recording sharp losses from October 30 to November 7. This came after the index surged more than 7 percent earlier in October as better-than-expected Q2 results and positive outlook for the second half of the ongoing financial year boosted investor sentiment.

This came despite delays to US-India trade deal negotiations

Hopes of nearing end to US government shutdown:

The US Senate on November 9 moved ahead with a measure aimed at reopening the federal government and ending a now 40-day-long shutdown. In a procedural vote, senators advanced a House-passed bill that will be amended to fund the government until January 30 and include a package of three full-year appropriations bills.

If the Senate passed the amended measure, it will be sent for approval by the House of Representatives and then to President Donald Trump for his signature. “It looks like we’re getting very close to the shutdown ending,” Trump told reporters at the White House.

As part of the shutdown, many government services have been suspended and hundreds of thousands of federal employees have been ordered not to work.

&quot;A possible end to the longest running U.S. shutdown is a positive for markets. Our expectation is that the next step is for a House vote on Wednesday, with the government set to re-open this Friday,&quot; said Prashant Newnaha, senior Asia-Pacific rates strategist at TD Securities.

Indian IT companies derive a major portion of their revenue from the US market. The potential end to the US shutdown in America may have boosted investor confidence for these stocks.

Jefferies in September chose TCS and Infosys as its top picks about the largecap IT stocks. It noted that both are “well placed” to deal with the $100K visa fell for the Indian IT sector.

Among the midcap stocks, Jefferies prefers Coforge.

Top IT gainers today:

Infosys shares were the top gainer on the Nifty IT index, rising nearly 3 percent to trade at Rs 1,519.70 apiece. HCL Tech, LTI Mindtree, Wipro and Mphasis shares meanwhile gained nearly 2 percent each.

Persistent Systems, Tata Consultancy Services (TCS), Coforge and Tech Mahindra shares rose over 1 percent each.

Also read: Our LIVE blog on stock market updates

(With inputs from Reuters)

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

The shares of National Aluminium Company (NALCO) and Torrent Pharmaceuticals recorded sharp gains on November 10 after their respective Q2 results announcements boosted investor confidence. Transformers and Rectifiers (TARIL) shares however tanked 20 percent to hit the lower circuit at Rs 313.55 apiece.

NALCO shares surged nearly 9 percent to trade at Rs 254.98 apiece, the highest level seen by the stock in 11 months. Torrent Pharmaceuticals jumped around 7 percent to hit a fresh 52-week high of Rs 3,830 apiece.

NALCO Q2 Results:

<a href="https://www.moneycontrol.com/india/stockpricequote/aluminium/nationalaluminiumcompany/NAC">NALCO</a> on November 7 reported a consolidated net profit of Rs 1,430 crore for Q2 FY26. This marks a 37% YoY rise from the Rs 1,046 crore net profit reported in Q2 FY25. The firm's revenue from operations meanwhile rose more than 7 percent YoY to Rs 4,292 crore.

Along with the Q2 results, the company also announced the first interim dividend of Rs 4 per equity share for the financial year 2026. The company has fixed November 14 as the record date to determine the eligibility of the shareholders set to receive the payment. The payment of the interim dividend shall be made on or before December 6 to all eligible shareholders, whose names appear in the Register of Members as on record date.

Torrent Pharma Q2 Results:

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/torrentpharmaceuticals/TP06">Torrent Pharma</a> on November 7 reported a net profit of Rs 591 crore for Q2 FY26, marking a 30.5 percent YoY rise from the Rs 453 crore net profit reported in the corresponding quarter of the previous financial year. The firm’s revenue from operations meanwhile rose over 14 percent YoY to Rs 3,302 crore.

Jefferies kept a ‘Buy’ call on the stock, with a target price of Rs 4,300 per share. This implies an upside potential of more than 20 percent from the stock’s previous closing price.

The international brokerage said that the firm’s September quarter earnings beat estimates, driven by stronger US and Brazil sales. It added that Indian market continued to see market-beating growth while supply disruptions cause decline in Germany’s CC growth.

Jefferies raised its FY26–28 EBITDA estimates for Torrent Pharma by 3 percent

Nuvama also kept a ‘Buy’ call on the stock, with a target price of Rs 4,180 apiece. This implies an upside potential of more than 20 percent from the stock’s previous closing price.

The international brokerage said that the firm’s revenue and EBITDA beat consensus estimate by 3 percent each. EBITDA margin of 32.8 percent was in line with forecast.

Transformers and Rectifiers (India) Q2 Results:

<a href="https://www.moneycontrol.com/india/stockpricequote/power-transmissionequipment/transformersrectifiersindia/TRI">Transformers and Rectifiers (India)</a> on November 8 reported a consolidated net profit of Rs 33.91 crore for Q2 FY26, marking a 25 percent YoY decrease from the Rs 45.25 crore net profit reported in the same quarter of the previous financial year.

The firm’s revenue from operations meanwhile saw marginal decline to Rs 460 crore during the July-September quarter of the ongoing financial year. EBITDA stood at Rs 65 crore, while EBITDA margin reduced to 13.81 percent.

Additionally, World Bank has debarred the company from participating in its financed projects over alleged corruption and fraud related to a $486 million Nigeria power grid project.

Also read: <a href="https://www.moneycontrol.com/news/business/earnings/q2-results-2025-live-updates-bajaj-finance-ongc-vodafone-idea-reliance-power-hudco-ather-energy-kec-international-quarterly-earnings-today-10-november-2025-liveblog-13663325.html">Our LIVE blog on Q2 updates</a>

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Q2 Results impact: NALCO, Torrent Pharma shares jump up to 9%, Transformers and Rectifiers hits 20% lower circuit

The shares of National Aluminium Company (NALCO) and Torrent Pharmaceuticals recorded sharp gains on November 10 after their respective Q2 results announcements boosted investor confidence. Transformers and Rectifiers (TARIL) shares however tanked 20 percent to hit the lower circuit at Rs 313.55 apiece.

NALCO shares surged nearly 9 percent to trade at Rs 254.98 apiece, the highest level seen by the stock in 11 months. Torrent Pharmaceuticals jumped around 7 percent to hit a fresh 52-week high of Rs 3,830 apiece.

NALCO Q2 Results:

NALCO on November 7 reported a consolidated net profit of Rs 1,430 crore for Q2 FY26. This marks a 37% YoY rise from the Rs 1,046 crore net profit reported in Q2 FY25. The firm's revenue from operations meanwhile rose more than 7 percent YoY to Rs 4,292 crore.

Along with the Q2 results, the company also announced the first interim dividend of Rs 4 per equity share for the financial year 2026. The company has fixed November 14 as the record date to determine the eligibility of the shareholders set to receive the payment. The payment of the interim dividend shall be made on or before December 6 to all eligible shareholders, whose names appear in the Register of Members as on record date.

Torrent Pharma Q2 Results:

Torrent Pharma on November 7 reported a net profit of Rs 591 crore for Q2 FY26, marking a 30.5 percent YoY rise from the Rs 453 crore net profit reported in the corresponding quarter of the previous financial year. The firm’s revenue from operations meanwhile rose over 14 percent YoY to Rs 3,302 crore.

Jefferies kept a ‘Buy’ call on the stock, with a target price of Rs 4,300 per share. This implies an upside potential of more than 20 percent from the stock’s previous closing price.

The international brokerage said that the firm’s September quarter earnings beat estimates, driven by stronger US and Brazil sales. It added that Indian market continued to see market-beating growth while supply disruptions cause decline in Germany’s CC growth.

Jefferies raised its FY26–28 EBITDA estimates for Torrent Pharma by 3 percent

Nuvama also kept a ‘Buy’ call on the stock, with a target price of Rs 4,180 apiece. This implies an upside potential of more than 20 percent from the stock’s previous closing price.

The international brokerage said that the firm’s revenue and EBITDA beat consensus estimate by 3 percent each. EBITDA margin of 32.8 percent was in line with forecast.

Transformers and Rectifiers (India) Q2 Results:

Transformers and Rectifiers (India) on November 8 reported a consolidated net profit of Rs 33.91 crore for Q2 FY26, marking a 25 percent YoY decrease from the Rs 45.25 crore net profit reported in the same quarter of the previous financial year.

The firm’s revenue from operations meanwhile saw marginal decline to Rs 460 crore during the July-September quarter of the ongoing financial year. EBITDA stood at Rs 65 crore, while EBITDA margin reduced to 13.81 percent.

Additionally, World Bank has debarred the company from participating in its financed projects over alleged corruption and fraud related to a $486 million Nigeria power grid project.

Also read: Our LIVE blog on Q2 updates

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Auto Ancillaries - Diesel Engines Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Auto Ancillaries - Diesel Engines industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q2 FY25-26

Stock News

Stocks to Watch Today: Glenmark Pharma, Alkem Labs, Syrma SGS, Vikran Engineering, Ather Energy, Jindal Stainless, Vodafone, Baazar Style in focus on 11 November

Goldman Sachs sells 0.1% stake in Kaynes Technology for Rs 44 crore

Q2 results impact: Graphite India, Epigral shares decline up to 7% on weak earnings, Krsnaa Diagnostics rises 8%

IT index rises nearly 2%, snaps 6-day losses on hopes of end to US govt shutdown; Infosys, HCLTech rise up to 3%

Q2 Results impact: NALCO, Torrent Pharma shares jump up to 9%, Transformers and Rectifiers hits 20% lower circuit

Auto Ancillaries - Diesel Engines Industry StocksCheck latest stock performance, list of stocks, earnings review & more details about the Auto Ancillaries - Diesel Engines industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q2 FY25-26

Stock News

Stocks to Watch Today: Glenmark Pharma, Alkem Labs, Syrma SGS, Vikran Engineering, Ather Energy, Jindal Stainless, Vodafone, Baazar Style in focus on 11 November

Goldman Sachs sells 0.1% stake in Kaynes Technology for Rs 44 crore

Q2 results impact: Graphite India, Epigral shares decline up to 7% on weak earnings, Krsnaa Diagnostics rises 8%

IT index rises nearly 2%, snaps 6-day losses on hopes of end to US govt shutdown; Infosys, HCLTech rise up to 3%

Q2 Results impact: NALCO, Torrent Pharma shares jump up to 9%, Transformers and Rectifiers hits 20% lower circuit

Auto Ancillaries - Diesel Engines Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Auto Ancillaries - Diesel Engines industry stocks.